Success in the life sciences industry has always required meeting demanding schedules within a difficult regulatory environment, but is increasingly coupled with low-cost targets and high facility utilization rates. Meeting these business objectives while navigating an increasingly complex environment, marked by sophisticated customers, increasing demand for product innovation, patent expiry, regulatory changes, and increased competition from generics, presents many challenges for capital investments globally. IPA applies deep expertise in successful life sciences project and system management, along with broad cross-industry expertise, to help owner organizations overcome the barriers to capital effectiveness.